Tea nanoparticles for immunostimulation and chemo-drug delivery in cancer treatment

Journal of Biomedical Nanotechnology

Volumn 10, Issue 6, 2014, Pages 1016-1029

  Yi, Sijia ^a   Wang, Yongzhong ^a   Huang, Yujian ^a   Xia, Lijin ^a   Sun, Leming ^a   Lenaghan, Scott C ^a   Zhang, Mingjun ^a  

^a University of Tennessee   (United States)

Author keywords

Cancer treatment; Drug delivery; Immunostimulation; Natural nanoparticles; Tea

Indexed keywords

ATOMIC FORCE MICROSCOPY; CELLS; DIALYSIS; DISEASES; DRUG DELIVERY; HEALTH; MEDICAL APPLICATIONS; ONCOLOGY; PHARMACODYNAMICS; SCANNING ELECTRON MICROSCOPY;

BIOMEDICAL APPLICATIONS; ELECTROPHORETIC LIGHT SCATTERING; EPIGALLOCATECHIN GALLATE; IMMUNOSTIMULATION; MCF-7 BREAST CANCER CELLS; MULTIFUNCTIONAL NANOCARRIER; ORGANIC NANOPARTICLES; TEA;

NANOPARTICLES;

CAFFEINE; DOXORUBICIN; EPIGALLOCATECHIN GALLATE; GAMMA INTERFERON INDUCIBLE PROTEIN 10; GRANULOCYTE COLONY STIMULATING FACTOR; INTERLEUKIN 6; NANOCARRIER; NANOPARTICLE; RANTES; TEA NANOPARTICLE; THEOBROMINE; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

ARTICLE; ATOMIC FORCE MICROSCOPY; BREAST CANCER; CANCER CELL; CANCER THERAPY; CELL STRAIN MCF 7; CHEMICAL ANALYSIS; CONTROLLED STUDY; CYTOTOXICITY; DRUG DELIVERY SYSTEM; DRUG UPTAKE; HUMAN; HUMAN CELL; IMMUNOSTIMULATION; IN VITRO STUDY; LIGHT SCATTERING; LUNG CANCER; MACROPHAGE; SCANNING ELECTRON MICROSCOPY; TEA; ZETA POTENTIAL;

ADJUVANTS, IMMUNOLOGIC; ANTINEOPLASTIC AGENTS; CAMELLIA SINENSIS; CELL LINE, TUMOR; DIFFUSION; DOXORUBICIN; HUMANS; IMMUNIZATION; NANOCAPSULES; NEOPLASMS, EXPERIMENTAL; PLANT EXTRACTS; TREATMENT OUTCOME;

EID: 84898459087     PISSN: 15507033     EISSN: 15507041     Source Type: Journal    
DOI: 10.1166/jbn.2014.1782     Document Type: Article

References (61)

1. E. Strable, J. E. Johnson, and M. G. Finn, Natural nanochemical building blocks: Icosahedral virus particles organized by attached oligonucleotides. Nano Lett. 4, 1385 (2004).
2. G. Zheng, J. Chen, H. Li, and J. D. Glickson, Rerouting lipoprotein nanoparticles to selected alternate receptors for the targeted delivery of cancer diagnostic and therapeutic agents. Proc. Natl. Acad. Sci. U.S.A. 102, 17757 (2005).
3. W. J. M. Mulder, G. J. Strijkers, G. A. F. van Tilborg, D. P. Cormode, Z. A. Fayad, and K. Nicolay, Nanoparticulate assemblies of amphiphiles and diagnostically active materials for multimodality imaging. Accounts Chem. Res. 42, 904 (2009).
4. M. Zhang, M. Liu, H. Prest, and S. Fischer, Nanoparticles secreted from ivy rootlets for surface climbing. Nano Lett. 8, 1277 (2008).
5. L. Xia, S. Lenaghan, M. Zhang, Z. Zhang, and Q. Li, Naturally occurring nanoparticles from English ivy: An alternative to metal-based nanoparticles for UV protection. J. Nanobiotechnol. 8, 12 (2010).
6. Y. Wang, L. Sun, S. Yi, Y. Huang, S. C. Lenaghan, and M. Zhang, Naturally occurring nanoparticles from arthrobotrys oligospora as a potential immunostimulatory and antitumor agent. Adv. Funct. Mater. 23, 2175 (2012).
7. P. M. Favi, S. Yi, S. C. Lenaghan, L. Xia, and M. Zhang, Inspiration from the natural world: From bio-adhesives to bio-inspired adhesives. J. Adhes. Sci. Technol. (2012), DOI: 10.1080/01694243.2012.691809.
8. D. P. Cormode, P. A. Jarzyna, W. J. M. Mulder, and Z. A. Fayad, Modified natural nanoparticles as contrast agents for medical imaging. Adv. Drug Delivery. Rev. 62, 329 (2010).
9. H. Negishi, J.-W. Xu, K. Ikeda, M. Njelekela, Y. Nara, and Y. Yamori, Black and green tea polyphenols attenuate blood pressure increases in stroke-prone spontaneously hypertensive rats. J. Nutr. 134, 38 (2004).
10. H. Chen, M. Zhang, Z. Qu, and B. Xie, Antioxidant activities of different fractions of polysaccharide conjugates from green tea (Camellia Sinensis). Food Chem. 106, 559 (2008).
11. G. Fassina, A. Buffa, R. Benelli, O. E. Varnier, D. M. Noonan, and A. Albini, Polyphenolic antioxidant (-)-epigallocatechin-3-gallate from green tea as a candidate anti-HIV agent. AIDS 16, 939 (2002).
12. S. G. Khan, S. K. Katiyar, R. Agarwal, and H. Mukhtar, Enhancement of antioxidant and phase II enzymes by oral feeding of green tea polyphenols in drinking water to SKH-1 hairless mice: Possible Role in Cancer Chemoprevention. Cancer Res. 52, 4050 (1992).
13. C. Chen, R. Yu, E. Owuor, and A. Tony Kong, Activation of antioxidant-response element (ARE), mitogen-activated protein kinases (MAPKs) and caspases by major green tea polyphenol components during cell survival and death. Arch. Pharm. Res. 23, 605 (2000).
14. J. Jankun, S. H. Selman, R. Swiercz, and E. Skrzypczak-Jankun, Why drinking green tea could prevent cancer. Nature 387, 561 (1997).
15. A. G. Paschka, R. Butler, and C. Y. F. Young, Induction of apoptosis in prostate cancer cell lines by the green tea component, (-)-epigallocatechin-3- gallate. Cancer Lett. 130, 1 (1998).
16. E. L. Wynder, D. P. Rose, and L. A. Cohen, Nutrition and prostate cancer: A proposal for dietary intervention. Nutr. Cancer 22, 1 (1994).
17. S. Pianetti, S. Guo, K. T. Kavanagh, and G. E. Sonenshein, Green tea polyphenol epigallocatechin-3 gallate inhibits her-2/neu signaling, proliferation, and transformed phenotype of breast cancer cells. Cancer Res. 62, 652 (2002).
18. S. Valcic, B. N. Timmermann, D. S. Alberts, G. A. Wächter, M. Krutzsch, J. Wymer, and J. M. Guillén, Inhibitory effect of six green tea catechins and caffeine on the growth of four selected human tumor cell lines. Anti-Cancer Drugs 7, 461 (1996).
19. S. K. Katiyar and H. Mukhtar, Tea antioxidants in cancer chemoprevention. J. Cell. Biochem. Suppl. 27, 59 (1997).
20. L. Y. Chung, T. C. Cheung, S. K. Kong, K. P. Fung, Y. M. Choy, Z. Y. Chan, and T. T. Kwok, Induction of apoptosis by green tea catechins in human prostate cancer DU145 cells. Life Sci. 68, 1207 (2001).
21. V. S. Thakur, K. Gupta, and S. Gupta, Green tea polyphenols causes cell cycle arrest and apoptosis in prostate cancer cells by suppressing class I histone deacetylases. Carcinogenesis 33, 377 (2012).
22. N. Khan and H. Mukhtar, Multitargeted therapy of cancer by green tea polyphenols. Cancer Lett. 269, 269 (2008).
23. X. Yang, Y. Zhao, Y. Yang, and Y. Ruan, Isolation and Characterization of immunostimulatory polysaccharide from an herb tea, gynostemma pentaphyllum makino. J. Agric. Food Chem. 56, 6905 (2008).
24. H. Chen, M. Zhang, and B. Xie, Quantification of uronic acids in tea polysaccharide conjugates and their antioxidant properties. J. Agric. Food Chem. 52, 3333 (2004).
25. R. Gröning, J. Breitkreutz, V. Baroth, and R. Stephanie Müller, Nanoparticles in plant extracts: Influence of drugs on the formation of nanoparticles and precipitates in black tea infusions. Eur. J. Pharm. Sci. 15, 149 (2002).
26. S. Nie, M. Xie, Z. Fu, Y. Wan, and A. Yan, Study on the purification and chemical compositions of tea glycoprotein. Carbohydr. Polym. 71, 626 (2008).
27. Y. Zuo, H. Chen, and Y. Deng, Simultaneous determination of catechins, caffeine and gallic acids in green, Oolong, black and pu-erh teas using HPLC with a photodiode array detector. Talanta 57, 307 (2002).
28. Y. Wang, L. Chen, Y. Ding, and W. Yan, Oxidized phospholipid based pH sensitive micelles for delivery of anthracyclines to resistant leukemia cells in vitro. Int. J. Pharm. 422, 409 (2012).
29. Y. Wang, J. Hao, Y. Li, Z. Zhang, X. Sha, L. Han, and X. Fang, Poly(caprolactone)-modified Pluronic P105 micelles for reversal of paclitaxcel-resistance in SKOV-3 tumors. Biomaterials 33, 4741 (2012).
30. J. F. Carpenter, T. W. Randolph, W. Jiskoot, D. J. A. Crommelin, C. R. Middaugh, and G. Winter, Potential inaccurate quantitation and sizing of protein aggregates by size exclusion chromatography: Essential need to use orthogonal methods to assure the quality of therapeutic protein products. J. Pharm. Sci. 99, 2200 (2010).
31. E. A. H. Roberts, The phenolic substances of manufactured tea. X. - the creaming down of tea liquors. J. Sci. Food Agric. 14, 700 (1963).
32. H. Horie and K. Kohata, Analysis of tea components by high-performance liquid chromatography and high-performance capillary electrophoresis. J. Chromatogr. A 881, 425 (2000).
33. Y. Lv, X. Yang, Y. Zhao, Y. Ruan, Y. Yang, and Z. Wang, Separation and quantification of component monosaccharides of the tea polysaccharides from Gynostemma pentaphyllum by HPLC with indirect UV detection. Food Chem. 112, 742 (2009).
34. H. Chen, Z. Wang, Z. Qu, L. Fu, P. Dong, and X. Zhang, Physicochemical characterization and antioxidant activity of a polysaccharide isolated from oolong tea. Eur. Food Res. Technol. 229, 629 (2009).
35. I. A. Schepetkin and M. T. Quinn, Botanical polysaccharides: Macrophage immunomodulation and therapeutic potential. Int. Immunopharmacol. 6, 317 (2006).
36. B. S. Paulsen, Plant polysaccharides with immunostimulatory activities. Curr. Org. Chem. 5, 939 (2001).
37. D. Wang, C. Wang, J. Li, and G. Zhao, Components and Activity of Polysaccharides from Coarse Tea. J. Agric. Food Chem. 49, 507 (2000).
38. J.-H. Lee, J. S. Shim, J. S. Lee, J. K. Kim, I. S. Yang, M.-S. Chung, and K. H. Kim, Inhibition of pathogenic bacterial adhesion by acidic polysaccharide from green tea (camellia sinensis). J. Agric. Food Chem. 54, 8717 (2006).
39. S. A. Eccles and P. Alexander, Macrophage content of tumours in relation to metastatic spread and host immune reaction. Nature 250, 667 (1974).
40. S. Gordon, Alternative activation of macrophages. Nat. Rev. Immunol. 3, 23 (2003).
41. T. Schioppa, R. Moore, R. G. Thompson, E. C. Rosser, H. Kulbe, S. Nedospasov, C. Mauri, L. M. Coussens, and F. R. Balkwill, B regulatory cells and the tumor-promoting actions of TNF-α during squamous carcinogenesis. Proc. Natl. Acad. Sci. U.S.A. 108, 10662 (2011).
42. R. van Horssen, T. L. M. ten Hagen, and A. M. M. Eggermont, TNF-α in Cancer treatment: Molecular insights, antitumor effects, and clinical utility. Oncologist 11, 397 (2006).
43. A. Lokshin, T. Raskovalova, X. Huang, L. C. Zacharia, E. K. Jackson, and E. Gorelik, Adenosine-mediated inhibition of the cytotoxic activity and cytokine production by activated natural killer cells. Cancer Res. 66, 7758 (2006).
44. E. H. Han, J. H. Choi, Y. P. Hwang, H. J. Park, C. Y. Choi, Y. C. Chung, J. K. Seo, and H. G. Jeong, Immunostimulatory activity of aqueous extract isolated from Prunella vulgaris. Food Chem. Toxicol. 47, 62 (2009).
45. F. Oliveira Silva, P. Neves Santos, C. Melo, E. Teixeira, B. Sousa Cavada, V. Pereira, A. Porto, J. Cajazeiras, F. Arruda, and A. Almeida, Immunostimulatory activity of ConBr: A focus on splenocyte proliferation and proliferative cytokine secretion. Cell Tissue Res. 346, 237 (2011).
46. M. Harada, Y. Qin, H. Takano, T. Minamino, Y. Zou, H. Toko, M. Ohtsuka, K. Matsuura, M. Sano, J. Nishi, K. Iwanaga, H. Akazawa, T. Kunieda, W. Zhu, H. Hasegawa, K. Kunisada, T. Nagai, H. Nakaya, K. Yamauchi-Takihara, and I. Komuro, G-CSF prevents cardiac remodeling after myocardial infarction by activating the Jak-Stat pathway in cardiomyocytes. Nat. Med. 11, 305 (2005).
47. J. Thomas, F. Liu, and D. C. Link, Mechanisms of mobilization of hematopoietic progenitors with granulocyte colony-stimulating factor. Curr. Opin. Hematol. 9, 183 (2002).
48. D. Metcalf, The colony-stimulating factors and cancer. Nat. Rev. Cancer 10, 425 (2010).
49. B. Homey, A. Müller, and A. Zlotnik, Chemokines: Agents for the immunotherapy of cancer?. Nat. Rev. Immunol. 2, 175 (2002).
50. J. J. Mulé, M. Custer, B. Averbook, J. C. Yang, J. S. Weber, D. V. Goeddel, S. A. Rosenberg, and T. J. Schall, RANTES secretion by gene-modified tumor cells results in loss of tumorigenicity in vivo: Role of immune cell subpopulations. Hum. Gene. Ther. 7, 1545 (1996).
51. K. B. Bacon, B. A. Premack, P. Gardner, and T. J. Schall, Activation of dual T cell signaling pathways by the chemokine RANTES. American Association for the Advancement of Science, ETATSUNIS, Washington, DC (1995), Vol. 269.
52. J. Keyser, J. Schultz, K. Ladell, L. Elzaouk, L. Heinzerling, J. Pavlovic, and K. Moelling, IP-10-encoding plasmid DNA therapy exhibits anti-tumor and anti-metastatic efficiency. Exp. Dermatol. 13, 380 (2004).
53. A. L. Angiolillo, C. Sgadari, D. D. Taub, F. Liao, J. M. Farber, S. Maheshwari, H. K. Kleinman, G. H. Reaman, and G. Tosato, Human interferon-inducible protein 10 is a potent inhibitor of angiogenesis in vivo. J. Exp. Med. 182, 155 (1995).
54. A. Mantovani, P. A. Gray, J. Van Damme, and S. Sozzani, Macrophage-derived chemokine (MDC). J. Leukoc. Biol. 68, 400 (2000).
55. X. Yang, S. Kootala, J. Hilborn, and D. A. Ossipov, Preparation of hyaluronic acid nanoparticles via hydrophobic association assisted chemical cross-linking-an orthogonal modular approach. Soft Matter 7, 7517 (2011).
56. C. Wang, L. Cheng, and Z. Liu, Drug delivery with upconversion nanoparticles for multi-functional targeted cancer cell imaging and therapy, Biomaterials 32, 1110 (2011).
57. J. O. Kim, A. V. Kabanov, and T. K. Bronich, Polymer micelles with cross-linked polyanion core for delivery of a cationic drug doxorubicin. J. Control Release 138, 197 (2009).
58. S. Ganta, H. Devalapally, A. Shahiwala, and M. Amiji, A review of stimuli-responsive nanocarriers for drug and gene delivery. J. Control Release 126, 187 (2008).
59. R. Singh and J. W. Lillard Jr, Nanoparticle-based targeted drug delivery. Exp. Mol. Pathol. 86, 215 (2009).
60. H. Meng, M. Liong, T. Xia, Z. Li, Z. Ji, J. I. Zink, and A. E. Nel, Engineered design of mesoporous silica nanoparticles to deliver doxorubicin and p-glycoprotein siRNA to overcome drug resistance in a cancer cell line. ACS Nano 4, 4539 (2010).
61. Y. Tang, T. Lei, R. Manchanda, A. Nagesetti, A. Fernandez-Fernandez, S. Srinivasan, and A. McGoron, Simultaneous delivery of chemotherapeutic and thermal-optical agents to cancer cells by a polymeric (PLGA) nanocarrier: An in vitro study. Pharm. Res. 27, 2242 (2010).